1 – 10 of 29
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        The DNA methylation landscape of primary triple-negative breast cancer
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Tumor purity estimated from bulk DNA methylation can be used for adjusting beta values of individual samples to better reflect tumor biology
    
    - Contribution to journal › Article
 
- 
                        Mark
        Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        SRIQ clustering : A fusion of Random Forest, QT clustering, and KNN concepts
    
    - Contribution to journal › Article
 
- 
                        Mark
        Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Molecular analyses of triple-negative breast cancer in the young and elderly
    
    - Contribution to journal › Article
 
- 
                        Mark
        Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    
    - Contribution to journal › Article
 
- 
                        Mark
        Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer : A Step in the Right Direction but Still a Long Way To Go.
    
    - Contribution to journal › Debate/Note/Editorial
 
